Effects of Angiotensin II Type 1 Receptor Blockade on β-Cell Function in Humans
Author:
Affiliation:
1. From the Division of Endocrinology, Carl T. Hayden VA Medical Center, Phoenix, Arizona
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/care/article-pdf/30/1/181/594544/zdc00107000181.pdf
Reference6 articles.
1. Carlsson PO, Berne C, Jansson L: Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127–133, 1998
2. Lau T, Carlsson PO, Leung PS: Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240–248, 2004
3. Fliser D, Schaefer F, Schmid D, Veldhuis JD, Ritz E: Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. Hypertension 30:1156–1161, 1997
4. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME: Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53:989–997, 2004
5. Chu KY, Lau T, Carlsson P-O, Leung PS: Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55:367–374, 2006
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation;Experimental & Molecular Medicine;2023-05-01
2. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update;High Blood Pressure & Cardiovascular Prevention;2021-02-26
3. Bone carriers in diabetic foot osteomyelitis;The Science, Etiology and Mechanobiology of Diabetes and its Complications;2021
4. The association of calcium channel blockers with β‐cell function in type 2 diabetic patients: A cross‐sectional study;The Journal of Clinical Hypertension;2019-03-22
5. Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine;Diabetes, Obesity and Metabolism;2018-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3